Data presented at EULAR 2026 confirm that tight disease control can lead to safe pregnancies but also expose a critical need ...
GLP-1 receptor agonists (GLP-1 RA) medications were shown to reduce the number of deaths, amputations and hospitalizations ...
Female sex, poor baseline patient-reported outcomes and tender vs. swollen joints are significant predictors of unacceptable ...
A new Northwestern Medicine study has discovered how radiotherapy alters the immune environment within cutaneous T-cell ...
A 2026 State-of-the-Art review updates the ABCs of cardiovascular disease prevention to help clinicians apply contemporary risk assessment, lifestyle, pharmacologic, and cardiometabolic strategies in ...
Pain remains one of the most prevalent and disabling non-motor consequences of neurological disease, yet it continues to be ...
Patients using GLP-1 RAs may experience dermatologic adverse side effects, including skin laxity, hair shedding, and facial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results